Neurodegenerative Diseases

Show Articles
Journal Properties
  • Country
    Switzerland
  • Language
    English
  • Number of Articles
    1,000
  • Abbreviation
    Neurodegener Dis
  • ISSN
    1660-2854
  • e-ISSN
    1660-2862
  • Main Publisher
    Karger
  • Publisher
    S. Karger AG
  • Indian UGC
  • DOAJ (latest)
Journal Properties
  • Medicine
    Internal medicine
    Neurosciences
    Biological psychiatry
    Neuropsychiatry
    Medicine
    Internal medicine
    Neurosciences
    Biological psychiatry
    Neuropsychiatry
    Neurology
    Diseases of the nervous system
  • website
Description
Neurodegenerative Diseases is a core publication providing a forum for basic, translational, and clinical research related to neurodegenerative disorders. It covers a wide spectrum of diseases, including AlzheimerÂ’s, ParkinsonÂ’s, HuntingtonÂ’s, and amyotrophic lateral sclerosis (ALS), offering important insights into disease mechanisms, diagnostic approaches, and therapeutic strategies. The journal publishes original research articles, reviews, and short communications, delving into molecular and cellular pathogenesis, genetics, biomarkers, and clinical trials. Neurodegenerative Diseases is indexed in prominent databases like PubMed, Scopus, and Web of Science. It caters to a broad audience of neuroscientists, neurologists, neuropathologists, and researchers working on the development of novel therapies for neurodegenerative conditions. By fostering the exchange of cutting-edge findings, the journal contributes significantly to the global effort to combat these devastating diseases. Submit your high-impact findings to contribute to advancements in the field. Your innovative research can play a role in enhancing understanding, diagnosis, and treatment of neurodegenerative diseases, fostering a brighter future for patients and families.